Spatial Heterogeneity of Enteric Fever in 2 Diverse Communities in Nepal.
Salmonella
Nepal
enteric fever
geospatial
typhoid
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
01 12 2020
01 12 2020
Historique:
entrez:
1
12
2020
pubmed:
2
12
2020
medline:
28
4
2021
Statut:
ppublish
Résumé
Typhoid fever is endemic in the urban Kathmandu Valley of Nepal; however, there have been no population-based studies of typhoid outside of this community in the past 3 decades. Whether typhoid immunization should be prioritized in periurban and rural communities has been unclear. We performed population-based surveillance for enteric fever in 1 urban catchment (Kathmandu) and 1 periurban and rural catchment (Kavrepalanchok) as part of the Surveillance for Enteric Fever in Asia Project (SEAP). We recruited individuals presenting to outpatient and emergency departments at 2 study hospitals with suspected enteric fever and performed blood cultures. Additionally, we conducted a household survey in each catchment area to characterize care seeking for febrile illness. We evaluated spatial heterogeneity in febrile illness, care seeking, and enteric fever incidence. Between September 2016 and September 2019, we enrolled 5736 participants with suspected enteric fever at 2 study hospitals. Among these, 304 (5.3%) were culture positive for Salmonella Typhi (249 [81.9%]) or Paratyphi A (55 [18.1%]). Adjusted typhoid incidence in Kathmandu was 484 per 100 000 person-years and in Kavrepalanchok was 615 per 100 000 person-years. While all geographic areas for which estimates could be made had incidence >200 per 100 000 person-years, we observed spatial heterogeneity with up to 10-fold variation in incidence between communities. In urban, periurban, and rural communities in and around Kathmandu, we measured a high but heterogenous incidence of typhoid. These findings provide some support for the introduction of conjugate vaccines in Nepal, including outside urban areas, alongside other measures to prevent enteric fever.
Sections du résumé
BACKGROUND
Typhoid fever is endemic in the urban Kathmandu Valley of Nepal; however, there have been no population-based studies of typhoid outside of this community in the past 3 decades. Whether typhoid immunization should be prioritized in periurban and rural communities has been unclear.
METHODS
We performed population-based surveillance for enteric fever in 1 urban catchment (Kathmandu) and 1 periurban and rural catchment (Kavrepalanchok) as part of the Surveillance for Enteric Fever in Asia Project (SEAP). We recruited individuals presenting to outpatient and emergency departments at 2 study hospitals with suspected enteric fever and performed blood cultures. Additionally, we conducted a household survey in each catchment area to characterize care seeking for febrile illness. We evaluated spatial heterogeneity in febrile illness, care seeking, and enteric fever incidence.
RESULTS
Between September 2016 and September 2019, we enrolled 5736 participants with suspected enteric fever at 2 study hospitals. Among these, 304 (5.3%) were culture positive for Salmonella Typhi (249 [81.9%]) or Paratyphi A (55 [18.1%]). Adjusted typhoid incidence in Kathmandu was 484 per 100 000 person-years and in Kavrepalanchok was 615 per 100 000 person-years. While all geographic areas for which estimates could be made had incidence >200 per 100 000 person-years, we observed spatial heterogeneity with up to 10-fold variation in incidence between communities.
CONCLUSIONS
In urban, periurban, and rural communities in and around Kathmandu, we measured a high but heterogenous incidence of typhoid. These findings provide some support for the introduction of conjugate vaccines in Nepal, including outside urban areas, alongside other measures to prevent enteric fever.
Identifiants
pubmed: 33258932
pii: 6013560
doi: 10.1093/cid/ciaa1319
pmc: PMC7705881
doi:
Substances chimiques
Typhoid-Paratyphoid Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
S205-S213Informations de copyright
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.
Références
PLoS One. 2012;7(1):e29119
pubmed: 22276105
J Infect Dis. 2018 Nov 10;218(suppl_4):S255-S267
pubmed: 30307563
Clin Infect Dis. 2017 Jun 1;64(11):1522-1531
pubmed: 28329181
J Infect Dis. 2018 Nov 10;218(suppl_4):S232-S242
pubmed: 29444257
PLoS Negl Trop Dis. 2017 Nov 27;11(11):e0006051
pubmed: 29176850
Lancet Infect Dis. 2019 Apr;19(4):369-381
pubmed: 30792131
PLoS One. 2010 Nov 15;5(11):e13988
pubmed: 21085575
J Infect Dis. 2018 Nov 10;218(suppl_4):S214-S221
pubmed: 28961918
Clin Infect Dis. 2016 Mar 15;62 Suppl 1:S17-22
pubmed: 26933015
N Engl J Med. 2019 Dec 5;381(23):2209-2218
pubmed: 31800986
Clin Infect Dis. 2020 Jul 29;71(Supplement_2):S71-S78
pubmed: 32725227
J Infect Dis. 2018 Nov 10;218(suppl_4):S188-S194
pubmed: 30304505
J Infect Dis. 2018 Nov 10;218(suppl_4):S268-S276
pubmed: 30184162
Open Biol. 2011 Oct;1(2):110008
pubmed: 22645647
PLoS One. 2014 Jan 06;9(1):e77974
pubmed: 24400067
N Engl J Med. 1987 Oct 29;317(18):1101-4
pubmed: 3657877